RTX Q1 2026 Performance and Full-Year Guidance Revision Explained

RTX revised guidance and performance expectations for Q1 2026

Based on the provided earnings transcript excerpts for RTX covering Q1 2026, the company discusses performance expectations and guidance mostly in terms of raising full-year outlook; the excerpts do not present a separate, explicitly revised standalone Q1 2026 quantitative guidance range (e.g., for revenue/EPS specific to Q1). Instead, management’s “revised guidance” items in the excerpts relate to the full year outlook, supported by the Q1 execution results.

1) Q1 2026 performance (what management says about results)

Management characterizes the start of 2026 as strong, citing:

• Raytheon top-line growth: “9% growth on the top line” for Raytheon in the first quarter. ¹
• Defense material receipts: 12 consecutive quarters and “13% growth” in those receipts. ¹
• Raytheon margin performance: “margins for Raytheon were 12.2% in the first quarter.” ¹
• Productivity improvement: “$32 million of year-over-year productivity improvement at Raytheon.” ¹

These Q1 performance points are used to justify changes to RTX’s broader outlook (not presented as a standalone Q1 forecast range in the excerpt).

2) Revised outlook that is explicitly raised (but it is full-year, not Q1-specific)

The excerpt includes a clear “raise” to RTX’s full-year guidance, driven by Q1 Raytheon performance and outlook visibility:

• Adjusted sales (full year): “raising our full year adjusted sales outlook by $500 million to a new range of $92.5 billion to $93.5 billion.” ²
  • RTX attributes part of this to Raytheon: “about $350 million” attributable to Raytheon performance in 1Q and what they see entering 2Q, and the rest to “about $500 million” total increase (with “lower eliminations at the RTX level”). ¹
• Organic sales growth (full year): expects “between 5% and 6% organic sales growth for the full year at the RTX level.” ²
• By segment (full year): commercial OE “mid-single digits” and commercial aftermarket “high single digits,” with defense “mid to high single digits” due to Raytheon’s increase. ²

For the bottom line and cash flow, the excerpt provides full-year targets:

• Adjusted EPS (full year): “increasing… by $0.10 on both the low and high end” to “between $6.70 and $6.90.” ²
• Drivers of EPS change: approximately “$0.05 of drop-through” on higher Raytheon sales, with the remainder from “below-the-line items, including lower interest expense.” ²
• Free cash flow (full year): remains “on track… between $8.25 billion and $8.75 billion.” ²

3) What this implies for “Q1 2026 performance expectations”

While the transcript does not provide a separate Q1 2026 numerical guidance range, management effectively signals that Q1 results are not just “met,” but used as evidence that the business is performing well and that the ramp should continue:

• Management explicitly ties strong execution in Q1 to continued performance expectations: “our execution and operational performance drove strong top and bottom line results in Q1.” ³
• Raytheon strength is described as being “dropped… through to our guide,” and management says “we’re seeing good drop-through” and that the business “is performing quite well.” ¹
• Management also indicates that margins/productivity and supply chain execution are incorporated into guidance (with a “revisit… in July” reference), implying confidence in the near-term run-rate supporting the revised outlook. ¹

Bottom line

• There is no explicit revised quantitative “Q1 2026 guidance range” (e.g., specific revenue/EPS targets for Q1 2026) in the provided excerpts.
• The excerpts instead show strong Q1 2026 performance (Raytheon revenue growth, receipts growth, Raytheon margin, productivity) and then apply that performance to revise the full-year RTX guidance upward (sales, EPS, and the defense sales growth outlook). ¹²

If you want, I can restate the guidance items that are clearly revised from the excerpt into a compact list, but the key point is that the revisions shown here are full-year, not a standalone Q1-only guidance update. ²